T1D progression is associated with loss of CD3<sup>+</sup>CD56<sup>+</sup> regulatory T cells that control CD8<sup>+</sup> T cell effector functions.
Ontology highlight
ABSTRACT: An unresolved issue in autoimmunity is the lack of surrogate biomarkers of immunological self-tolerance for disease monitoring. Here, we show that peripheral frequency of a regulatory T cell population, characterized by the co-expression of CD3 and CD56 molecules (TR3-56), is reduced in subjects with new-onset type 1 diabetes (T1D). In three independent T1D cohorts, we find that low frequency of circulating TR3-56 cells is associated with reduced β-cell function and with the presence of diabetic ketoacidosis. As autoreactive CD8+ T cells mediate disruption of insulin-producing β-cells1-3, we demonstrate that TR3-56 cells can suppress CD8+ T cell functions in vitro by reducing levels of intracellular reactive oxygen sp
SUBMITTER: Terrazzano G
PROVIDER: S-EPMC7272221 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA